Xylo Technologies Ltd. MDGS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • IL • USD

SharesGrow Score

33/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Xylo Technologies Ltd. (MDGS) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 31/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

33/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

健康

50/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

22/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — MDGS

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.04

EV/EBITDA0.0

每股数据

EPS (TTM)$-9.50

每股账面价值$0.00

每股营收$54.40

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2014	$0.00	$684.14K	$-5.81M	-849.4%
2015	$0.00	$618.91K	$-9.48M	-1531.7%
2016	$-786.00	$549K	$-9.01M	-1640.6%
2017	$-69.88	$467K	$-2.55M	-545%
2018	$-47.14	$436K	$-6.6M	-1513.3%
2019	$-2.72	$273K	$-14.18M	-5193.4%
2020	$-0.77	$531K	$-6.85M	-1290%
2021	$0.13	$10.12M	$4.05M	40%
2022	$-6.28	$91.86M	$-10.21M	-11.1%
2023	$-9.50	$91.72M	$-16.03M	-17.5%